Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
Authors:
- Kelly L. HaywardKHKelly L. Hayward
- Patricia C. ValeryPVPatricia C. Valery
- W. Neil CottrellWCW. Neil Cottrell
- Katharine M. IrvineKIKatharine M. Irvine
- Leigh U. HorsfallLHLeigh U. Horsfall
- Caroline J. TallisCTCaroline J. Tallis
- Veronique S. ChachayVCVeronique S. Chachay
- Brittany J RuffinBRBrittany J Ruffin
- Jennifer H. MartinJMJennifer H. Martin
- Elizabeth E. PowellEPElizabeth E. Powell
Open Access
- 13 September 2016
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 114
Abstract
Cirrhosis patients are prescribed multiple medications for their liver disease and comorbidities. Discrepancies between medicines consumed by patients and those documented in the medical record may contribute to patient harm and impair disease management. The aim of the present study was to assess the magnitude and types of discrepancies among patient-reported and medical record-documented medications in patients with cirrhosis, and examine factors associated with such discrepancies. Fifty patients who attended a hospital hepatology outpatient clinic were interviewed using a questionnaire composed of mixed short-response and multiple-choice questions. Patients’ reported medication use was compared with documentation in the hospital medical records and pharmacy database. Medication adherence was assessed using the 8-question ©Morisky Medication Adherence Scale (MMAS-8). The multivariate logistic regression model was constructed using clinically relevant and/or statistically significant variables as determined by univariate analysis. All p-values were 2-sided (α = 0.05). Twenty-seven patients (54.0 %) had ≥1 discrepancy between reported and documented medicines. Patients with ≥1 discrepancy were older (p = 0.04) and multivariate analysis identified taking ≥5 conventional medicines or having a ‘low’ or ‘medium’ adherence ranking as independent predictors of discrepancy (adjusted OR 11.0 (95 % CI 1.8–67.4), 20.7 (95 % CI 1.3–337.7) and 49.0 (95 % CI 3.3–718.5) respectively). Concordance was highest for liver disease medicines (71.9 %) and lowest for complementary and alternative medicines (14.5 %) and respiratory medicines (0 %). There is significant discrepancy between sources of patient medication information within the hepatology clinic. Medication reconciliation and medicines-management intervention may address the complex relationship between medication discrepancies, number of medications and patient adherence identified in this study.Keywords
This publication has 33 references indexed in Scilit:
- Adherence to Medications after Hospital Discharge in the ElderlyInternational Journal of Family Medicine, 2013
- Risk Factors for Frequent Readmissions and Barriers to Transplantation in Patients with CirrhosisPLOS ONE, 2013
- Utilizing community pharmacy dispensing records to disclose errors in hospital admission drug chartsInt. Journal of Clinical Pharmacology and Therapeutics, 2012
- Prognostic indicators of survival in patients with compensated and decompensated cirrhosisLiver International, 2012
- Hospital Readmissions Among Patients With Decompensated CirrhosisAmerican Journal of Gastroenterology, 2012
- Improving the measurement of self-reported medication nonadherence: Response to AuthorsJournal of Clinical Epidemiology, 2011
- Adverse reactions to complementary medicines: the Australian pharmacy experienceInternational Journal of Pharmacy Practice, 2010
- Measurements of medication adherence in diabetic patients with poorly controlled HbA1cDiabetic Medicine, 2010
- Posthospital Medication DiscrepanciesArchives of internal medicine (1960), 2005
- Polypharmacy and Medication Adherence. Small Steps on a Long RoadJournal of General Internal Medicine, 2001